Tryptophanol

Tryptophanol

SCHEMBL5151476

CC(C)c1cccc(-c2ccccc2C(=O)N[C@@H](CO)Cc2c[nH]c3ccccc23)c1.CC(C)c1cccc(-c2ccccc2C(=O)O)c1.N[C@@H](CO)Cc1c[nH]c2ccccc12

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 4/20 0.46
CCND1 P24385 4/20 0.46
ITGB2 P05107 7/20 0.43
ICAM1 P05362 7/20 0.43
ITGAL P20701 7/20 0.43
POLB P06746 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ECE1 P42892 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
BACE1 P56817 1/20 0.42
HTT P42858 1/20 0.42
AKT1 P31749 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5149438 0.92 CDK4 (0.52) CDK4CCND1ITGB2ICAM1ITGAL
Tryptophanol SCHEMBL5154467 0.89 ITGB2 (0.50) CDK4CCND1ITGB2ICAM1ITGAL
SCHEMBL5152530 0.82 ITGB2 (0.55) CDK4CCND1ITGB2ICAM1ITGAL
SCHEMBL5149376 0.81 CDK4 (0.53) CDK4CCND1ITGB2ICAM1ITGAL
SCHEMBL5149264 0.80 ERAP2 (0.47) CDK4CCND1ITGB2ICAM1ITGAL
SCHEMBL5155616 0.80 ERAP2 (0.47) CDK4CCND1ITGB2ICAM1ITGAL
SCHEMBL5151665 0.79 HPGDS (0.58) CDK4CCND1ITGB2ICAM1ITGAL
SCHEMBL5151298 0.78 POLB (0.47) ITGB2ICAM1ITGALPOLBMEN1
Tryptophanol SCHEMBL5155750 0.77 MEN1 (0.48) CDK4CCND1ITGB2ICAM1ITGAL
SCHEMBL5149272 0.77 ITGB2 (0.50) ITGB2ICAM1ITGALPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R CDK4 4400/4885CCND1 592/4885ITGB2 4080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.